KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacira BioSciences (PCRX) Other financing activities: 2010-2017

  • Pacira BioSciences' Other financing activities was N/A to $11.0 million in Q1 2017 from the same period last year, while for Mar 2017 it was $19.6 million, marking a year-over-year change of. This contributed to the annual value of $1.2 million for FY2022, which is 74.15% down from last year.
  • According to the latest figures from Q1 2017, Pacira BioSciences' Other financing activities is $11.0 million, which was up 52.97% from $7.2 million recorded in Q1 2013.
  • Over the past 5 years, Pacira BioSciences' Other financing activities peaked at $11.0 million during Q1 2017, and registered a low of $7.2 million during Q1 2013.
  • Moreover, its 1-year median value for Other financing activities was $11.0 million (2017), whereas its average is $11.0 million.
  • Data for Pacira BioSciences' Other financing activities shows a peak YoY surged of 1,966.38% (in 2013) over the last 5 years.
  • Pacira BioSciences' Other financing activities (Quarterly) stood at $7.2 million in 2013, then followed by $11.0 million in 2017.
  • Its last three reported values are $11.0 million in Q1 2017, $7.2 million for Q1 2013, and $1.0 million during Q2 2012.